Silo Pharma, Inc. (NASDAQ:SILO) filed a Form 8-K with the Securities and Exchange Commission on February 23, 2026, disclosing a material event.
Silo Pharma, Inc.'s stock currently trades at $0.28 with a market capitalization of $3.5M. The Healthcare company's stock moved following the disclosure.